drugset / Trial / NCT01908972

The Safety and Efficiency of Propranolol as an Initial Treatment for Pediatric Hemangioma

NCT01908972

Phase 4 Completed 34 enrolled Seoul National University Hospital
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to determine the safety and efficiency of Propranolol as an initial treatment for pediatric hemangioma.

Timeline

Start
2013-06
Primary completion
2015-05
Completion
2015-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Prednisolone Other / unclassified 2 mg/kg
Subject Propranolol Small molecule 2 mg/kg

Indications